Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
KlothoBios is a private U.S. longevity-focused biotech startup associated with Leonhardt Ventures and Leonhardt's Launchpads. The company is centered on the biology of the klotho protein and appears to operate both a research/education effort and an early commercial testing offering under the KlothoYears brand. Publicly available materials indicate that KlothoBios markets a klotho blood test for research/informational use and is also developing proprietary bioelectric stimulation approaches intended to increase or regulate klotho levels in vivo. Its stated disease interests span healthy aging and multiple age-related conditions, but there is no clear evidence of a disclosed clinical-stage therapeutic pipeline. Overall, KlothoBios appears to be an early-stage longevity biotech and diagnostics company with a strong platform orientation rather than a conventional late-stage drug developer.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on KlothoBios.